Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular triamcinolone for hip osteoarthritis
2011-000213-39Phase 4Active
- Sponsor
- Erasmus MC
- Start
- May 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in hip osteoarthritis comparing Intramuscular triamcinolone acetate with Saline placebo (2 arms). Primary endpoints: Change in WOMAC pain score at 2 weeks, Change in numerical rating scale pain at rest at 2 weeks and 1 more. Started May 2011; status: active.
02
Drugs
triamcinolone acetonide
03
Conditions
hip osteoarthritis
Beyond the preview
Go deeper on 2011-000213-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000213-39.